Rare diseases
Investigational molecules
Locations
Back to Czechia17 clinical trials in Horni Predmesti, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia
CzechiaStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
CzechiaStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cardiovascular disease prevention and treatment, with studies evaluating new therapeutic approaches for reducing major cardiovascular events.
Advanced trials exploring novel treatments for atherosclerotic cardiovascular disease prevention.
Comprehensive studies addressing various forms of lipid disorders, including trials for hypertriglyceridemia and hypercholesterolemia management.
Multiple trials evaluating new compounds for improving lipid profiles and patient outcomes.
Specialized research focusing on atrial fibrillation treatments, including comparative studies of novel anticoagulation approaches.
Groundbreaking studies examining new therapeutic options for patients with irregular heart rhythms.
Clinical investigations targeting heart failure treatment through combination therapy approaches and innovative drug development.
Evaluating novel therapeutic combinations to enhance outcomes in heart failure patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
